Brian D. Piper's Insider Trades & SAST Disclosures

Brian D. Piper's most recent trade in Prelude Therapeutics Inc was a trade of 115,650 Employee Stock Option (Right to Buy) done . Disclosure was reported to the exchange on July 20, 2021.

Share

Note

This is a custom search result for pattern Brian D. Piper.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.

All Superstars

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Show

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Prelude Therapeutics Inc High Gain High Volume	Brian D. Piper	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jul 2021	115,650	115,650	-		-	Employee Stock Option (Right to Buy)
Prelude Therapeutics Inc High Gain High Volume	Brian D. Piper	Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.89 per share.	25 May 2021	8,333	8,333	-	1.9	15,749	Common Stock
Prelude Therapeutics Inc High Gain High Volume	Brian D. Piper	Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	25 May 2021	8,333	272,662	-		-	Employee Stock Option (Right to Buy)
Prelude Therapeutics Inc High Gain High Volume	Brian D. Piper	Chief Financial Officer	Sale of securities on an exchange or to another person at price $ 33.53 per share.	25 May 2021	3,110	5,223	-	33.5	104,263	Common Stock
Prelude Therapeutics Inc High Gain High Volume	Brian D. Piper	Chief Financial Officer	Sale of securities on an exchange or to another person at price $ 34.11 per share.	25 May 2021	3,088	2,135	-	34.1	105,338	Common Stock
Prelude Therapeutics Inc High Gain High Volume	Brian D. Piper	Chief Financial Officer	Sale of securities on an exchange or to another person at price $ 35.45 per share.	25 May 2021	1,736	399	-	35.4	61,536	Common Stock
Prelude Therapeutics Inc High Gain High Volume	Brian D. Piper	Chief Financial Officer	Sale of securities on an exchange or to another person at price $ 36.09 per share.	25 May 2021	399	0	-	36.1	14,401	Common Stock

Showing 1 to 7 of 7 entries

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades